4//SEC Filing
FLAUM SANDER A 4
Accession 0001209191-18-017705
CIK 0000827871other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:16 PM ET
Size
8.9 KB
Accession
0001209191-18-017705
Insider Transaction Report
Form 4
FLAUM SANDER A
Director
Transactions
- Exercise/Conversion
Common Stock
2018-03-05$0.90/sh+2,340$2,106→ 13,714 total - Sale
Common Stock
2018-03-06$53.94/sh−2,340$126,220→ 11,374 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-05−2,340→ 0 totalExercise: $0.90Exp: 2018-03-06→ Common Stock (2,340 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.79 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The option is fully vested and immediately exercisable.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001261026
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:16 PM ET
- Size
- 8.9 KB